Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Presenting the Case for Smart Insulin Pens

Presenting the Case for Smart Insulin Pens c CAPSULES | CLINICAL MATTERS PRESENTING THE CASE FOR SMART INSULIN PENS JANICE MACLEOD, MA, RD, CDCES, FADCES Out of the 7.4 million individuals on insulin therapy Challenges With MDI Therapy in the US today, the vast majority rely on injections Forget to Take Insulin for insulin delivery, with only 10% to 15% using Even when people take their insulin, they basic or smart insulin pumps. A small but growing sometimes can’t remember if they took the dose number are using inhaled insulin. Many people or not. This can lead to a dangerous quandary. with diabetes (PWD) need the availability of tools Do they inject and risk double dosing, putting to help them with dosing support, but they don’t themselves at risk of severe hypoglycemia? Or, want the inconvenience, cost, complexity, or do they not inject and risk missing out having commitment of an insulin pump. injected at all, which could lead to hyperglycemia? Now, an entirely new category of insulin Then, of course, sometimes people intentionally delivery, smart insulin pens (SIPs), off ers dosing omit insulin doses perhaps due to inconvenience, support with the convenience and lower cost embarrassment, or skipping a meal. Missing just of a simple, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png ADCES in Practice SAGE

Presenting the Case for Smart Insulin Pens

MacLeod, Janice
ADCES in Practice , Volume 8 (4): 5 – Jul 1, 2020
Download PDF
5 pages

Loading next page...
 
/lp/sage/presenting-the-case-for-smart-insulin-pens-S4GNPUOcVy

References (12)

Publisher
SAGE
Copyright
© 2020 by the American Association of Diabetes Educators
ISSN
2633-559X
eISSN
2633-5603
DOI
10.1177/2633559X20925462
Publisher site
See Article on Publisher Site

Abstract

c CAPSULES | CLINICAL MATTERS PRESENTING THE CASE FOR SMART INSULIN PENS JANICE MACLEOD, MA, RD, CDCES, FADCES Out of the 7.4 million individuals on insulin therapy Challenges With MDI Therapy in the US today, the vast majority rely on injections Forget to Take Insulin for insulin delivery, with only 10% to 15% using Even when people take their insulin, they basic or smart insulin pumps. A small but growing sometimes can’t remember if they took the dose number are using inhaled insulin. Many people or not. This can lead to a dangerous quandary. with diabetes (PWD) need the availability of tools Do they inject and risk double dosing, putting to help them with dosing support, but they don’t themselves at risk of severe hypoglycemia? Or, want the inconvenience, cost, complexity, or do they not inject and risk missing out having commitment of an insulin pump. injected at all, which could lead to hyperglycemia? Now, an entirely new category of insulin Then, of course, sometimes people intentionally delivery, smart insulin pens (SIPs), off ers dosing omit insulin doses perhaps due to inconvenience, support with the convenience and lower cost embarrassment, or skipping a meal. Missing just of a simple,

Journal

ADCES in Practice – SAGE

Published: Jul 1, 2020

There are no references for this article.